TEE
APYX icon

Tibra Equities Europe’s Apyx Medical APYX Stock Holding History

Tibra Equities Europe’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-58,453
Closed -$369K – 249
2019
Q1 		$369K Buy
+58,453
New +$452K 0.04% 304

Other funds holding APYX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tibra Equities Europe's APYX Position: Q2 2019 in Review

Tibra Equities Europe sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 58,453 shares — an estimated $369K sold.

Tibra Equities Europe first reported a position in APYX in Q1 2019 and held it in 1 quarter. The position peaked at $369K in Q1 2019. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

  • Tibra Equities Europe reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 58,453 Apyx Medical shares in Q2 2019, an estimated $369K.
  • Tibra Equities Europe first reported a position in Apyx Medical in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Apyx Medical position peaked at $369K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.